by Charlie Helps FRSA | Jul 22, 2026 | Corporate Governance
Whilst 76% of corporate directors utilise artificial intelligence in their board activities, a mere 8% report having the expertise required to oversee it. You likely recognise that this expertise gap creates a vacuum where algorithmic reliance erodes institutional...
by Charlie Helps FRSA | Jul 20, 2026 | Corporate Governance
Intentions are not assurance. A Board may harbour the most virtuous aspirations for patient safety; however, without the structural discipline to translate these desires into evidenced movement, they remain regulatory vulnerabilities. Achieving CQC compliance is not a...
by Charlie Helps FRSA | Jul 15, 2026 | Corporate Governance
Reliance is not a passive act of trust; it is a calculated exercise of judgement rooted in the veracity of evidence. Many UK directors currently struggle with a difficult paradox: they are inundated with data yet starved of clarity. Reports frequently focus on...
by Charlie Helps FRSA | Jul 14, 2026 | Corporate Governance
Table of Contents NHS Risk Management: Beyond Compliance to Institutional Assurance The Triad of Modern NHS Risk: Clinical, Financial, and Digital Implementing a Functional Risk Management Framework The Board’s Authority in Risk Mitigation and Workflow Optimisation...
by Charlie Helps FRSA | Jul 10, 2026 | Corporate Governance
Institutional safety is not a passive byproduct of policy; it is the result of deliberate, high-level oversight. Many directors find themselves adrift in a sea of clinical data, struggling to synthesise complex metrics into the board-level insights required for true...
